Bone BiologicsBBLG
13F holders, Q2 2025 (June 30)4holders
$4.03avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Bone Biologics Corp. (BBLG) in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($806), Clear Street LLC ($556) and UBS Group AG ($455).
- Company
- Bone Biologics Corp.
- CUSIP
- 098070600
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2K |
| Exits | 0 | $0 |
Ownership 4 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 200 | $806 |
| Clear Street LLC | 0.00% | New | 138 | $556 |
| UBS Group AG | 0.00% | New | 113 | $455 |
| Bank of America Corp. | 0.00% | New | 4 | $16 |
"% of holder's portfolio" is BBLG's weight in each manager's 13F, not the share of Bone Biologics Corp. the manager owns.